Skip to main content
AFT PHARMACEUTICALS LIMITED logo

AFT PHARMACEUTICALS LIMITED — Investor Relations & Filings

Ticker · AFP ASX Manufacturing
Open in API
Filings indexed 461 across all filing types
Latest filing 2026-05-24 Regulatory Filings
Country AU Australia
Listing ASX AFP

About AFT PHARMACEUTICALS LIMITED

https://www.aftpharm.com/

AFT Pharmaceuticals Limited focuses on the development, licensing, and distribution of a diverse range of healthcare products. The company specializes in therapeutic areas such as pain management, eye care, dermatology, and allergy relief. Its primary proprietary product is Maxigesic, a patented combination of paracetamol and ibuprofen designed for enhanced analgesic effect, which is licensed in numerous international markets. The company maintains a robust pipeline of research and development projects aimed at creating innovative delivery systems and formulations. AFT Pharmaceuticals manages a portfolio comprising both prescription and over-the-counter medicines. Its business strategy involves direct sales operations in specific regions alongside a global licensing model that extends its product reach to over 100 countries. The company prioritizes clinical evidence and intellectual property to support its commercial growth and product efficacy.

Recent filings

Filing Released Lang Actions
Annual Meeting and Closing Date for Director Nominations 1 page 129.0KB
Regulatory Filings Classification · 90% confidence The document is a brief regulatory announcement of the upcoming annual shareholders’ meeting date, location, and director nomination deadline, with notice that full details will be distributed later. It does not contain the actual Notice of Meeting or proxy materials (PSI), nor any substantive report data. It’s a general regulatory announcement that doesn’t fit any more specific category, so it falls under Regulatory Filings (RNS).
2026-05-24 English
Issue of unlisted options 2 pages 224.8KB
Share Issue/Capital Change Classification · 92% confidence The document is a New Zealand Exchange (NZX) Capital Change Notice detailing the issue of 495,000 unlisted options under the company’s Long Term Incentive Plan, including exercise price, vesting conditions, authority, and timing. This is a direct announcement of a capital change (issue of convertible financial products/options), matching the “Share Issue/Capital Change” category (Code: SHA).
2026-05-21 English
Dividend/Distribution - AFP 5 pages 18.5KB
Notice of Dividend Amount Classification · 93% confidence The document is an Appendix 3A.1 Notification of dividend/distribution, detailing the dividend amount per security, ex-date, record date, payment date, currency, and tax treatment. This matches a Notice of Dividend Amount announcement rather than a full report or regulatory filing. Therefore, it is classified as a dividend notice (DIV).
2026-05-21 English
FY26 results 5 pages 195.3KB
Earnings Release Classification · 95% confidence The document is a high-level summary announcing full-year financial results for the year ended 31 March 2026, providing key metrics (revenue, EBITDA, profit, dividend, guidance) and highlights without detailed financial statements. It states the full annual report is separately released. This matches the definition of an Earnings Release (ER). FY 2026
2026-05-20 English
FY26 results presentation 24 pages 4.6MB
Investor Presentation Classification · 95% confidence The document is structured as a slide deck titled “INVESTOR PRESENTATION” with detailed financial performance, strategic outlook, growth targets, and R&D pipeline information. It is clearly a presentation prepared for investors rather than a formal regulatory filing or full report. This matches the definition of an Investor Presentation (Code: IP).
2026-05-20 English
FY26 Annual Report 122 pages 4.5MB
Annual Report Classification · 95% confidence The document is a comprehensive annual report for the fiscal year to 31 March 2026, including financial and strategic highlights, Chair and Managing Director’s report, consolidated financial statements, governance, remuneration, sustainability, statutory disclosures, and appendices. It contains audited financial statements prepared in accordance with accounting standards and covers full-year performance. This matches the definition of an official Annual Report (Code: 10-K). FY 2026
2026-05-20 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.